期刊
JOURNAL OF PHARMACOLOGICAL SCIENCES
卷 152, 期 2, 页码 151-161出版社
JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1016/j.jphs.2023.04.007
关键词
Neuroinflammation; Autophagy; Paeoniflorin; Ferulic acid; Atractylenolide III
PF, FA, and ATL individually or in combination showed significant reduction in inflammatory factor production and increased expression of autophagy-related proteins in LPS-induced neuroinflammation in BV2 microglia cells. The best therapeutic effect was observed with the combination of all three compounds, and their protective effect may be through activation of the AMPK/ULK1/TFEB autophagic signaling pathway.
Microglia hyperactivation is an important cause of neuroinflammation in Alzheimer's disease (AD). Paeoniflorin (PF), ferulic acid (FA), and atractylenolide III (ATL) are potent in anti-inflammation and neuroprotection. Multiple components can act on different targets simultaneously to exert synergistic therapeutic effects and exploring the synergistic potential between compounds is an important area of research. We investigated the effects of PF, FA, and ATL, alone or in combination, on LPS-induced neu-roinflammation and autophagy in BV2 microglia cells. We found that PF, FA, and ATL, alone or in com-bination, significantly reduced the production of inflammatory factors such as IL-6, IL-113, and TNF-a, especially in the PF thorn FA thorn ATL group, which performed the best. In addition, the combination of PF, FA, and ATL significantly increased the expression of autophagy-related proteins p-AMPK, p-ULK1, Beclin1, LC3, and TFEB and decreased the expression of p62. Moreover, the restoration of autophagic flux by the combination of PF, FA, and ATL was abrogated by the addition of the autophagy inhibitor Wortmannin. In conclusion, PF, FA, and ATL have a synergistic effect in reducing LPS-induced inflammatory factor release from BV2 microglia cells, and its protective effect may be through activation of the AMPK/ULK1/TFEB autophagic signaling pathway.(c) 2023 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据